Vaginal progesterone as luteal phase support in natural cycle frozen-thawed embryo transfer (ProFET): protocol for a multicentre, open-label, randomised controlled trial.

Autor: Stadelmann C; University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden caroline.stadelmann@vgregion.se.; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Gothenburg, Sweden., Bergh C; University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden.; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Gothenburg, Sweden., Brännström M; University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden.; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Gothenburg, Sweden., Olsen KH; Livio Fertility Center, Reykjavik, Iceland, Reykjavik, Iceland., Khatibi A; University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden.; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Gothenburg, Sweden., Kitlinski M; Department of Reproductive Medicine, Skåne University Hospital Malmö Reproductive Medicine Centre, Malmo, Sweden., Liffner S; Department of Biomedical and Clinical Sciences, Division of Children's and Women's Health, Linkoping University Hospital Obstetrics and Gynecology, Linkoping, Sweden., Lundborg E; Nordic IVF, Gothenburg, Sweden, Gothenburg, Sweden., Rodriguez-Wallberg KA; Department of Reproductive Medicine, Division of Gynecology and Reproduction, Karolinska Universitetssjukhuset, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Strandell A; University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden.; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Gothenburg, Sweden., Westlander G; Livio Fertility Center Göteborg, Goteborg, Sweden., Widlund G; Departement of Reproductive Medicine, University Hospital of Örebro, Sweden, Örebro universitet Fakulteten för medicin och hälsa, Örebro, Sweden., Magnusson Å; University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden.; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Publikováno v: BMJ open [BMJ Open] 2022 Jul 08; Vol. 12 (7), pp. e062400. Date of Electronic Publication: 2022 Jul 08.

Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs.

Autor: Gopaul VS; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Pieterman EJ; The Netherlands Organization for Applied Scientific Research (TNO)-Metabolic Health Research, Leiden, Netherlands., Princen HMG; The Netherlands Organization for Applied Scientific Research (TNO)-Metabolic Health Research, Leiden, Netherlands., Bergenholm L; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lundborg E; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Cavallin A; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Johansson MJ; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hawthorne G; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Björkbom A; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hammarberg M; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden., Li X; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jarke A; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bright J; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK., Svensson L; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jansson-Löfmark R; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Abrahamsson B; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. Electronic address: bertil.abrahamsson@AstraZeneca.com., Agrawal R; Global Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hurt-Camejo E; Early CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Publikováno v: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2021 Jun 01; Vol. 161, pp. 105776. Date of Electronic Publication: 2021 Mar 02.

[Private egg bank to protect fertility against aging].

Autor: Wennberg AL, Lundborg E, Zachrisson U, Nielsen S, Saldeen P, Brännström M

Publikováno v: Lakartidningen [Lakartidningen] 2014 Apr 29-May 13; Vol. 111 (18-19), pp. 793-5.

Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.

Autor: Quan YS; Department of Biopharmaceutics, Kyoto Pharmaceutical University, Japan., Hattori K, Lundborg E, Fujita T, Murakami M, Muranishi S, Yamamoto A

Publikováno v: Biological & pharmaceutical bulletin [Biol Pharm Bull] 1998 Jun; Vol. 21 (6), pp. 615-20.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.